Oxford Performance Materials received a three-year, $150,000 grant from the National Institutes of Health, according to a Today's Medical Developments report.
The grant will fund research conducted by Dr. Adam Hacking, PhD, to improve treatment methods for infections associated with implanted devices. The NIH's National Institute of Arthritis and Musculoskeletal and Skin Disease provided the funding.
Dr. Hacking is the chief scientific officer for OPM, which produces devices for artificial hips, knees and other implantables with the advanced applications of three-dimensional printing of PEKK.
Since device-related infections can result in prolonged patient suffering and expected costs of $12 billion next year, there is a huge opportunity in this area.